A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

Status unconfirmed · Phase 3 · Has a placebo group

Conditions studied: Osteoarthritis, Knee

In brief

This is a randomized, double-blind, placebo-controlled, 24-week study to evaluate the efficacy and safety of AXS-02 in subjects with knee osteoarthritis associated with bone marrow lesions.

Key facts

Study ID
NCT02746068
Run by
Axsome Therapeutics, Inc.
People needed
346
Starts
2016-03-01
Expected to finish
2020-12-01
Last updated by the study team
2019-01-10

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.